• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.肥胖相关代谢并发症的起源:脂肪组织与游离脂肪酸转运。
Curr Opin Clin Nutr Metab Care. 2011 Nov;14(6):535-41. doi: 10.1097/MCO.0b013e32834ad8b6.
2
[Characteristics of free fatty acid metabolism in pathogenesis of obesity: current view].[肥胖发病机制中游离脂肪酸代谢的特征:当前观点]
Vopr Pitan. 2018;87(1):18-27. doi: 10.24411/0042-8833-2018-10002. Epub 2017 Dec 18.
3
Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?肥胖症中脂肪组织脂肪酸转运的下调:异位脂肪沉积的驱动因素?
Diabetes. 2011 Jan;60(1):47-55. doi: 10.2337/db10-0867. Epub 2010 Oct 13.
4
Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.栀子苷对自发性肥胖 2 型糖尿病小鼠和游离脂肪酸处理 HepG2 细胞代谢疾病状态的预防作用。
Biol Pharm Bull. 2011;34(10):1613-8. doi: 10.1248/bpb.34.1613.
5
Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.针对脂肪组织炎症以治疗肥胖代谢并发症的潜在病因。
Nestle Nutr Inst Workshop Ser. 2012;73:49-60; discussion p61-6. doi: 10.1159/000341287. Epub 2012 Oct 29.
6
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.肥胖的代谢性肝病及脂肪组织在非酒精性脂肪性肝病发病机制中的作用。
World J Gastroenterol. 2007 Jul 14;13(26):3540-53. doi: 10.3748/wjg.v13.i26.3540.
7
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.非酒精性脂肪性肝病(NAFLD)及其与胰岛素抵抗、血脂异常、动脉粥样硬化和冠心病的关系。
Nutrients. 2013 May 10;5(5):1544-60. doi: 10.3390/nu5051544.
8
Adipose tissue dysfunction in obesity.肥胖中的脂肪组织功能障碍。
Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8.
9
Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患者葡萄糖、脂肪酸和 VLDL 动力学及多器官胰岛素敏感性的可重复性。
Int J Obes (Lond). 2011 Sep;35(9):1233-40. doi: 10.1038/ijo.2010.265. Epub 2010 Dec 21.
10
Features, functions, and associated diseases of visceral and ectopic fat: a comprehensive review.内脏脂肪和异位脂肪的特征、功能及相关疾病:综述
Obesity (Silver Spring). 2025 May;33(5):825-838. doi: 10.1002/oby.24239. Epub 2025 Mar 12.

引用本文的文献

1
FABP4 as a Mediator of Lipid Metabolism and Pregnant Uterine Dysfunction in Obesity.脂肪酸结合蛋白4作为肥胖中脂质代谢和妊娠子宫功能障碍的介质
Adv Sci (Weinh). 2025 Jul;12(25):e2501077. doi: 10.1002/advs.202501077. Epub 2025 Apr 7.
2
Association between gamma-glutamyl transferase and diabetes factors among elderly nonobese individuals.老年非肥胖个体中γ-谷氨酰转移酶与糖尿病相关因素之间的关联。
Medicine (Baltimore). 2025 Mar 21;104(12):e41913. doi: 10.1097/MD.0000000000041913.
3
Effects of root extract on adipogenesis and lipogenesis in 3T3-L1 adipocytes and SD rat models.根提取物对3T3-L1脂肪细胞和SD大鼠模型中脂肪生成和脂质生成的影响。
Nutr Res Pract. 2024 Apr;18(2):180-193. doi: 10.4162/nrp.2024.18.2.180. Epub 2024 Mar 21.
4
Identification of oleic acid as an endogenous ligand of GPR3.鉴定出油酸是 GPR3 的内源性配体。
Cell Res. 2024 Mar;34(3):232-244. doi: 10.1038/s41422-024-00932-5. Epub 2024 Jan 29.
5
Extract of Inhibits Lipid Accumulation in In Vitro and In Vivo by Regulating Oxidative Stress.提取物通过调节氧化应激在体外和体内抑制脂质积累。
Antioxidants (Basel). 2023 Jul 14;12(7):1426. doi: 10.3390/antiox12071426.
6
Association Analysis of Triglyceride Glucose-Body Mass Index and Bone Turnover Markers in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者甘油三酯血糖-体重指数与骨转换标志物的关联分析
Diabetes Metab Syndr Obes. 2023 May 18;16:1435-1447. doi: 10.2147/DMSO.S406849. eCollection 2023.
7
A Skeletal Muscle-Centric View on Time-Restricted Feeding and Obesity under Various Metabolic Challenges in Humans and Animals.从骨骼肌角度探讨限时进食在人类和动物各种代谢挑战下与肥胖的关系。
Int J Mol Sci. 2022 Dec 27;24(1):422. doi: 10.3390/ijms24010422.
8
Noninvasive NMR/MRS Metabolic Parameters to Evaluate Metabolic Syndrome in Rats.用于评估大鼠代谢综合征的非侵入性核磁共振波谱/磁共振波谱代谢参数
Diagnostics (Basel). 2022 Jul 4;12(7):1621. doi: 10.3390/diagnostics12071621.
9
Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes.针对肥胖症和糖尿病中的G蛋白偶联雌激素受体(GPER)
Endocr Metab Sci. 2021 Mar 31;2. doi: 10.1016/j.endmts.2021.100080. Epub 2021 Jan 20.
10
MicroRNA-100 Reduced Fetal Bovine Muscle Satellite Cell Myogenesis and Augmented Intramuscular Lipid Deposition by Modulating IGF1R.微小 RNA-100 通过调节 IGF1R 减少胎儿牛肌肉卫星细胞的成肌作用并增加肌内脂质沉积。
Cells. 2022 Jan 28;11(3):451. doi: 10.3390/cells11030451.

本文引用的文献

1
Predictors of ectopic fat accumulation in liver and pancreas in obese men and women.肥胖男女性患者肝、胰外脂肪堆积的预测因子。
Obesity (Silver Spring). 2011 Sep;19(9):1747-54. doi: 10.1038/oby.2011.114. Epub 2011 May 19.
2
Myocardial, perivascular, and epicardial fat.心肌、血管周围和心外膜脂肪。
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S371-9. doi: 10.2337/dc11-s250.
3
Nine days of intensive exercise training improves mitochondrial function but not insulin action in adult offspring of mothers with type 2 diabetes.9 天的强化运动训练可改善 2 型糖尿病母亲后代成年人的线粒体功能,但不能改善胰岛素作用。
J Clin Endocrinol Metab. 2011 Jul;96(7):E1137-41. doi: 10.1210/jc.2010-2863. Epub 2011 Apr 20.
4
Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities.人类肥胖的特征是脂肪储存缺陷和肌肉脂肪酸氧化增强,曲美他嗪逐渐逆转这些异常。
Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E105-12. doi: 10.1152/ajpendo.00680.2010. Epub 2011 Apr 19.
5
Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.骨骼肌脂肪酶表达和活性的改变导致人类胰岛素抵抗。
Diabetes. 2011 Jun;60(6):1734-42. doi: 10.2337/db10-1364. Epub 2011 Apr 15.
6
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.基于长期增加肝脏脂肪酸氧化的肥胖和糖尿病的分子治疗。
Hepatology. 2011 Mar;53(3):821-32. doi: 10.1002/hep.24140. Epub 2011 Feb 11.
7
From chronic overfeeding to hepatic injury: role of endoplasmic reticulum stress and inflammation.从慢性过食到肝损伤:内质网应激和炎症的作用。
Nutr Metab Cardiovasc Dis. 2011 Mar;21(3):222-30. doi: 10.1016/j.numecd.2010.10.012. Epub 2011 Feb 1.
8
Paradoxical increase in TAG and DAG content parallel the insulin sensitizing effect of unilateral DGAT1 overexpression in rat skeletal muscle.单侧 DGAT1 过表达在大鼠骨骼肌中增加 TAG 和 DAG 含量,同时增加胰岛素敏感性。
PLoS One. 2011 Jan 14;6(1):e14503. doi: 10.1371/journal.pone.0014503.
9
Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects.体脂百分比与 BMI 定义的正常体重人群中心血管代谢失调有关。
Nutr Metab Cardiovasc Dis. 2012 Sep;22(9):741-7. doi: 10.1016/j.numecd.2010.11.009. Epub 2011 Jan 7.
10
Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility.胰岛素抵抗中的骨骼肌线粒体:肌间纤维与亚肌小节膜下亚群的差异,以及与代谢灵活性的关系。
J Clin Endocrinol Metab. 2011 Feb;96(2):494-503. doi: 10.1210/jc.2010-0822. Epub 2010 Nov 24.

肥胖相关代谢并发症的起源:脂肪组织与游离脂肪酸转运。

Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.

机构信息

Division of Geriatrics and Nutritional Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

Curr Opin Clin Nutr Metab Care. 2011 Nov;14(6):535-41. doi: 10.1097/MCO.0b013e32834ad8b6.

DOI:10.1097/MCO.0b013e32834ad8b6
PMID:21849896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3711689/
Abstract

PURPOSE OF REVIEW

Obesity is associated with a number of serious medical complications that are risk factors for cardiovascular disease (e.g., insulin resistance, dyslipidemia, and liver fat accumulation). Alterations in fatty acid trafficking, both between tissues and within cells, represent a key feature in the pathophysiology of the metabolic complications in obese patients. The ways by which fatty acid 're-routing' may affect metabolic function are summarized in this article.

RECENT FINDINGS

Ectopic fat accumulation (i.e., fat accumulation in nonadipose tissues) appears to be a key feature distinguishing metabolically healthy from metabolically abnormal patients. This observation has led to the belief that an imbalance in fatty acid trafficking away from adipose tissue toward nonadipose tissues is a primary cause for the development of metabolic alterations in obese patients. More recently, however, it has become apparent that fatty acid trafficking within nonadipose tissues cells (i.e., toward storage - in the form of triglycerides - and oxidation) may be equally important in determining a person's risk for development of metabolic disease.

SUMMARY

The pathophysiology of the metabolic alterations associated with obesity is probably multifactorial within a complex network of coordinated physiological responses. Only through the integration of multiple concepts, will it be possible to further our understanding in this area and to help prevent the metabolic alterations associated with obesity.

摘要

目的综述

肥胖与许多严重的医学并发症相关,这些并发症是心血管疾病的危险因素(如胰岛素抵抗、血脂异常和肝脂肪堆积)。脂肪酸在组织间和细胞内的转运改变是肥胖患者代谢并发症病理生理学的一个关键特征。本文总结了脂肪酸“再分配”可能影响代谢功能的方式。

最近的发现

异位脂肪堆积(即脂肪在非脂肪组织中的堆积)似乎是区分代谢健康和代谢异常患者的一个关键特征。这一观察结果导致人们相信,脂肪从脂肪组织向非脂肪组织的不平衡转运是肥胖患者代谢改变发展的主要原因。然而,最近人们已经意识到,非脂肪组织细胞内的脂肪酸转运(即朝着储存的方向——以甘油三酯的形式——和氧化)对于确定一个人患代谢性疾病的风险同样重要。

总结

肥胖相关代谢改变的病理生理学可能是一个复杂的生理反应协调网络中的多因素。只有通过整合多个概念,才有可能进一步加深我们在这一领域的理解,并帮助预防肥胖相关的代谢改变。